نتایج جستجو برای: cancer dual targeting nanobody nrp

تعداد نتایج: 1169826  

Maryam Hosseini Nader Riahi Alam, Sadegh Dehghani Soheila Haghgoo Tohid Mortezazadeh

Introduction: Noninvasive magnetic resonance imaging (MRI) and targeted drug delivery systems, usually referred to as theranostic agents, are being developed to enable detection, site-specific treatment, and long-term monitoring.   Materials and Methods: To elucidate the effects of coating on cellular uptake and biodistribution of n...

Journal: :Molecular medicine reports 2015
Zhengxiang Han Guan Jiang Yingying Zhang Jie Xu Chong Chen Lansheng Zhang Zhenyuan Xu Xiuping Du

Lentiviral expression vectors carrying human NRP-1 short hairpin RNA (shRNA) were constructed and selected to present highly efficient NRP-1/shRNA interference sequences, in order to investigate the effects of RNA interference (RNAi)-mediated NRP-1 silencing on the biological activities of breast cancer cells. Three pairs of human NRP-1 targeted specific interference sequences and one pair of n...

2016
Pratiek N. Matkar Krishna Kumar Singh Dmitriy Rudenko Yu Jin Kim Michael A. Kuliszewski Gerald J. Prud'homme David W. Hedley Howard Leong-Poi

Pancreatic ductal adenocarcinoma (PDAC) is characterized by an intense fibrotic reaction termed tumor desmoplasia, which is in part responsible for its aggressiveness. Endothelial cells have been shown to display cellular plasticity in the form of endothelial-to-mesenchymal transition (EndMT) that serves as an important source of fibroblasts in pathological disorders, including cancer. Angiogen...

Arash Arashkia, Fatemeh Hajari Taheri, Jamshid Hadjati, Mahmoud Hassani, Mohammad Hossein Modarressi, Mohsen Abolhassani, Shahriyar Abdoli, Wytske M. van Weerden, Zahra Sharifzadeh,

Background: Recently, modification of T cells with chimeric antigen receptor (CAR) has been an attractive approach for adoptive immunotherapy of cancers. Typically, CARs contain a single-chain variable domain fragment (scFv). Most often, scfvs are derived from a monoclonal antibody of murine origin and may be a trigger for host immune system that leads to the T-cell clearance. Nanobody is a spe...

2012
Marissa J. Stanton Samikshan Dutta Heyu Zhang Navatha S. Polavaram Alexey A. Leontovich Frank A. Sinicrope Donald J. Tindall Michael H. Muders Kaustubh Datta

A major contributor to cancer mortality is recurrence and subsequent metastatic transformation following therapeutic intervention. Therefore, in order to develop new treatment modalities and improve the efficacy of current ones, it is important to understand themolecularmechanisms that promote resistance to therapy in cancer cells. One pathway contributing to therapy resistance is autophagy, a ...

2011
Camille Grandclement Christophe Borg

Recent investigations highlighted strong similarities between neural crest migration during embryogenesis and metastatic processes. Indeed, some families of axon guidance molecules were also reported to participate in cancer invasion: plexins/semaphorins/neuropilins, ephrins/Eph receptors, netrin/DCC/UNC5. Neuropilins (NRPs) are transmembrane non tyrosine-kinase glycoproteins first identified a...

2016
Ting Li Shali Qi Mandy Unger Yun Nan Hou Qi Wen Deng Jun Liu Connie M. C. Lam Xian Wang Wang Du Xin Peng Zhang Friedrich Koch-Nolte Quan Hao Hongmin Zhang Hon Cheung Lee Yong Juan Zhao

CD38, as a cell surface antigen is highly expressed in several hematologic malignancies including multiple myeloma (MM) and has been proven to be a good target for immunotherapy of the disease. CD38 is also a signaling enzyme responsible for the metabolism of two novel calcium messenger molecules. To be able to target this multifunctional protein, we generated a series of nanobodies against CD3...

2013
Wei-Hai Chen Xiao-Ding Xu Guo-Feng Luo Hui-Zhen Jia Qi Lei Si-Xue Cheng Ren-Xi Zhuo Xian-Zheng Zhang

Mitochondria are vital organelles to eukaryotic cells. Damage to mitochondria will cause irreversible cell death or apoptosis. In this report, we aim at programmed cancer cell death via specific mitochondrial damage. Herein, a functionalized pro-apoptotic peptide demonstrates a dual-targeting capability using folic acid (FA) (targeting agent I) and triphenylphosphonium (TPP) cation (targeting a...

Journal: :Molecular cancer therapeutics 2012
Maria J W D Vosjan Jo Vercammen Joost A Kolkman Marijke Stigter-van Walsum Hilde Revets Guus A M S van Dongen

Hepatocyte growth factor (HGF) and its receptor c-Met are associated with increased aggressiveness of tumors and poor prognostic outcome of patients with cancer. Here, we report the development and characterization of therapeutic anti-HGF (αHGF)-Nanobodies and their potential for positron emission tomographic (PET) imaging to assess HGF expression in vivo. Two αHGF-Nanobodies designated 1E2 and...

2017
Peter Bannas Julia Hambach Friedrich Koch-Nolte

Monoclonal antibodies have revolutionized cancer therapy. However, delivery to tumor cells in vivo is hampered by the large size (150 kDa) of conventional antibodies. The minimal target recognition module of a conventional antibody is composed of two non-covalently associated variable domains (VH and VL). The proper orientation of these domains is mediated by their hydrophobic interface and is ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید